Athersys, Inc
ATHXDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001368148
Athersys, Inc was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 21, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $1.18M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Athersys, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 117 | 44 | −73 |
| SharesConverted for a 1-for-25 split | 1.67M | 2.23M | +551.4K (+32.9%) |
| Value | $10.9M | $4.11M | −$6.78M (−62.3%) |
New holders (4)
Institutions that held Athersys, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 528,565 | $978.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 61,879 | $114.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,275 | $4.00K | 0.00% |
| Royal Bank of Canada | 86 | $0 | 0.00% |
Sold out (77)
Institutions that held Athersys, Inc at the end of Q2 2022 and filed for Q3 2022 without it.